A synthetic polypeptide conjugate from a 42-residue polypeptide and salicylhydroxamic acid binds human myeloperoxidase with high affinity.

作者: Xiaojiao Sun , Jie Yang , Thomas Norberg , Lars Baltzer

DOI: 10.1002/PSC.2459

关键词:

摘要: This thesis describes the design and synthesis of small molecule derivatives their polypeptide conjugates as high affinity binders for proteins: D-dimer protein (D-dimer), a biomarker diagnosis thromboembolic diseases; human myeloperoxidase (MPO), cardiovascular chitinases, potential targets asthma therapy. The interactions between synthetic binder molecules those proteins were evaluated by surface plasmon resonance (SPR) biosensor analysis fluorescence spectroscopy. Competition SPR experiments or other methods proved that components critical binding specifically bound to original site molecules. consisted 42-residue helix-loop-helix conjugated via aliphatic spacers suitable length. could be any type moderately structure. In development D-dimer, tetrapeptide GPRP with dissociation constant Kd 25 μM was used 4C15L8GPRP obtained estimated approximately 3 nM. MPO, salicylhydroxamic acid (SHA) 2 4C37L34C11SHA 0.4 theobromine derivative (pentoxifylline) 43±10 4C37L34-P considerably higher than pentoxifylline. identified from 16-membered pool candidates conjugating each member set 16 designed polypeptides. affinities greatly enhanced 2-3 orders magnitude, compared molecule. polypeptides did not bind measurable affinities. discovery these new can pave way diagnostic tests in vivo vitro, independent antibodies.

参考文章(15)
M Ikeda-Saito, D A Shelley, L Lu, K S Booth, W S Caughey, S Kimura, Salicylhydroxamic acid inhibits myeloperoxidase activity. Journal of Biological Chemistry. ,vol. 266, pp. 3611- 3616 ,(1991) , 10.1016/S0021-9258(19)67838-5
Adam T. Ślósarczyk, Lars Baltzer, The molecular recognition of phosphorylated proteins by designed polypeptides conjugated to a small molecule that binds phosphate. Organic and Biomolecular Chemistry. ,vol. 9, pp. 7697- 7704 ,(2011) , 10.1039/C1OB06154B
Daniel E. Aultz, Arthur R. McFadden, Howard B. Lassman, Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 3. .omega.-(6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-yl)alkanoic acids Journal of Medicinal Chemistry. ,vol. 20, pp. 1499- 1501 ,(1977) , 10.1021/JM00221A028
Aline Hoy, David Trégouët, Brigitte Leininger-Muller, Odette Poirier, Mickaël Maurice, Catherine Sass, Gérard Siest, Laurence Tiret, Sophie Visvikis, Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. European Journal of Human Genetics. ,vol. 9, pp. 780- 786 ,(2001) , 10.1038/SJ.EJHG.5200702
Claire L. Heslop, Jiri J. Frohlich, John S. Hill, Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. Journal of the American College of Cardiology. ,vol. 55, pp. 1102- 1109 ,(2010) , 10.1016/J.JACC.2009.11.050
Domenick Papa, Erwin Schwenk, Hilda Hankin, Friedel-Crafts Synthesis of ι-Aroyl Aliphatic Acids1 Journal of the American Chemical Society. ,vol. 69, pp. 3018- 3022 ,(1947) , 10.1021/JA01204A024
Stephen J. Nicholls, Stanley L. Hazen, Myeloperoxidase and Cardiovascular Disease Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 25, pp. 1102- 1111 ,(2005) , 10.1161/01.ATV.0000163262.83456.6D